Back to top

Image: Bigstock

What's in the Cards for IDEX (IEX) this Earnings Season?

Read MoreHide Full Article

Industrial goods manufacturer, IDEX Corporation (IEX - Free Report) is scheduled to report first-quarter 2017 results after the closing bell on Apr 19. In the last reported quarter, adjusted earnings beat the Zacks Consensus Estimate by 3 cents. IDEX’s earnings track record has been quite healthy, having beaten estimates in three of the trailing four quarters with an average beat of 4.89%.

Let's see how things are shaping up for the upcoming quarterly results.

Key Factors in the Quarter

With operations across five continents, IDEX’s performance is exposed to the adverse impact of macroeconomic cycles in the U.S. and international markets. Rising dollar strength and unfavorable foreign currency movements are further likely to add to the woes and impact its bottom line.

In addition, the company operates in a highly competitive industry. Maintaining and improving its competitive position entails continued investment in manufacturing, engineering, quality standards, and support and distribution networks. This involves huge recurring R&D expenses that increase its operating costs. This also reduces IDEX’s price control over its products, which often leads to loss of market share, decline in top-line growth and lower operating margin. The impending quarterly results are likely to witness these trends as well, affecting its bottom line.

For the to-be-reported-quarter, IDEX’s revenues are anticipated to be affected by the volatility in the market as it procures substantial amount of raw materials and components from suppliers across the globe. This makes it susceptible to various operating risks, including the availability and prices for raw materials, curtailment or change in parts and components, interruptions in production by suppliers and prevailing price levels.

However, IDEX is striving to counter the muted growth environment by improving productivity and conducting heavy restructuring initiatives across its portfolio. At the same time, it aims to exploit suitable acquisition opportunities to fuel its inorganic growth momentum. These acquisitions expand its geographic reach, fill technology gaps and strengthen its foothold in the existing markets along with expanding its product lines.

The company also aims to increase its market exposure and improve sales mix by continually developing new products. With a flexible yet disciplined focus on expenses and productivity, it intends to optimize the cost structure, increase competitiveness and reallocate resources to improve profitability.

Earnings Whispers

Our proven model does not conclusively show that IDEX is likely to beat earnings this quarter as it does not possess the key components. A stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), #2 (Buy) or #3 (Hold) for this to happen. This is not the case here as you will see below:

Zacks ESP: Earnings ESP, which represents the difference between the Most Accurate estimate and the Zacks Consensus Estimate, is currently pegged at 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

IDEX Corporation Price and EPS Surprise

 

IDEX Corporation Price and EPS Surprise | IDEX Corporation Quote

Zacks Rank: IDEX has a Zacks Rank #4 (Sell).

As it is we caution against stocks with a Zacks Rank #4 or #5 (Sell-rated) going into the earnings announcement, especially when the company is seeing a negative estimate revisions momentum.

Stocks to Consider

Here are some companies that you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat this quarter:

Eli Lilly and Company (LLY - Free Report) has an Earnings ESP of +1.04% and a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.

BB&T Corporation has an Earnings ESP of +4.29% and a Zacks Rank #3.

Panera Bread Company has an Earnings ESP of +2.21% and a Zacks Rank #2.

Sell These Stocks. Now.

Just released, today's 220 Zacks Rank #5 Strong Sells demand urgent attention. If any are lurking in your portfolio or Watch List, they should be removed immediately. These are sinister companies because many appear to be sound investments. However, from 1988 through 2016, stocks from our Strong Sell list have actually performed 6X worse than the S&P 500.  

See today's Zacks "Strong Sells" absolutely free >>.


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Eli Lilly and Company (LLY) - free report >>

IDEX Corporation (IEX) - free report >>

Published in